Requests that the FDA Require Abbreviated New Drug Applications for Metronidazole Oral Suspension Products to Demonstrate Comparable Acceptable Taste Relative to LIKMEZ® (metronidazole) Oral Suspension | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

Open for Comments

FDA-2026-P-7928

Requests that the FDA Require Abbreviated New Drug Applications for Metronidazole Oral Suspension Products to Demonstrate Comparable Acceptable Taste Relative to LIKMEZ® (metronidazole) Oral Suspension

Documents

Comments

Key Dates

Comment Period OpensJul 23, 2026

Documents

Type	Title	Posted	Comments	Status
Other	Acknowledgement Letter from FDA DMB to Upadhye Tang LLP on behalf of Saptalis Pharmaceuticals, LLC	Jul 23, 2026	--

Keywords

CDER

Citizen Petition

Upadhye Tang LLP

Saptalis Pharmaceuticals LLC

Require Abbreviated New Drug Applications

for Metronidazole

Oral Suspension Products to Demonstrate

Comparable Acceptable Taste Relative to

Data from Regulations.gov